ZNF703: A novel oncogene involved in breast cancer;ZNF703: Un nouvel oncogène du cancer du sein

Medecine/Sciences

Volumn 27, Issue 4, 2011, Pages 357-359

  Ginestier, Christophe ^a   Sircoulomb, Fabrice ^a   Charafe Jauffret, Emmanuelle ^a   Chaffanet, Max ^a   Birnbaum, Daniel ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CARRIER PROTEIN; HYBRID PROTEIN; MULTIPROTEIN COMPLEX; NUCLEAR PROTEIN; ZNF703 PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; CANCER STEM CELL; CELL TRANSFORMATION; CHROMOSOME 8; DRUG RESISTANCE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; ONCOGENE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 8; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; ONCOGENES; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC;

EID: 79955630718     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011274008     Document Type: Article

References (10)

1. Charafe-Jauffret E, Chaffanet M, Bertucci F, et al. Towards an integrated cellular and molecular: definition of breast cancers. Med Sci Paris 2007; 23: 626-632. (Pubitemid 47099725)
2. Charafe-Jauffret E, Monville F Ginestier C, et al. Cancer stem cells in breast: current opinion and future challenges. Pathobiology 2008; 75: 75-84. (Pubitemid 351820725)
3. Ginestier C, Korkaya H, Dontu G, Birnbaum D, Wicha MS, Charafe-Jauffret E. The cancer stem cell: the breast cancer driver. Med Sci Paris 2007; 23: 1133-1139.
4. Sircoulomb F, Nicolas N, Ferrari A, et al. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Mol Med 2011; 3: 153-166.
5. Holland D, Burleigh A, Git A, et al. ZNF703, a luminal B breast cancer oncogene, is a transcriptional repressor and differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med 2011; 3: 167-180.
6. Turner N, Pearson A, Sharpe R, et al. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res 2010; 70: 2085-2094.
7. Zhang J, Liu X, Datta A, et al. RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest 2009; 119: 2171-2183.
8. Bernard-Pierrot I, Gruel N, Stransky N, et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 2008; 68: 7165-7175.
9. Kwek SS, Roy R, Zhou H, et al. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene 2009; 28: 1892-1903.
10. Nakamura M, Runko AP, Sagerstrom CG. A novel subfamily of zinc finger genes involved in embryonic development. J Cell Biochem 2004; 93: 887-895. (Pubitemid 44264144)